Elligo sets up new partnership in Canada

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Motortion)
(Image: Getty/Motortion)

Related tags: Elligo Health Research

Elligo Health Research partners with Jack Nathan Health to provide clinical research as a care option to patients at its Walmart clinics in Canada.

The partnership further expands Elligo’s growing ‘Research Ready’ site network. The company earlier this year raised $20m in Series C funding​ to support the company’s goal of connecting physicians and their patients to clinical trials.

“This partnership bridges real world health care needs with the ever-increasing need for patient participation in clinical research,”​ said Eli Alford, vice president, global operations - research operations, Elligo Health Research.

“Uniquely, it brings innovative treatments directly to patients – through their trusted physician – effectively putting them at the center of the process, making participation convenient and comfortable, and ultimately increasing study enrollment and retention rates,”​ he told us.

Jack Nathan Health CEO George Barakat said the biggest benefit is to the patients, as the partnership improves access to clinical trials for two million patients annually at the clinic.

“It makes participating in research as care for their condition convenient and cost-effective,”​ Barakat told us.

“Beyond the patient benefits, JNH will have the opportunity to enhance its engagement and relationship with its patients by expanding its research capabilities without investing in a dedicated department,”​ he added. “The partnership will also help Elligo fulfill its mission to expand and diversify the patient pool and help sponsors bring better-quality products to market faster.”

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more